author-photo

Anne-Charlotte de Gouville

GlaxoSmithKline

6

Papers

552

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia

2019 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (1)
Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist.

2015 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (9)
GSK256073 acutely regulates NEFA levels via HCA2 agonism but does not achieve durable glycaemic control in type 2 diabetes. A randomised trial.

2015 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (12)
Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis

2005 British Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (138)
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression

2003 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (90)
Expression of connective tissue growth factor in experimental rat and human liver fibrosis.

1999 Hepatology
Show All
- Source
- Cite
- Save
Citations (302)